REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 448 filers reported holding REPLIGEN CORP in Q4 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $216,511 | -0.8% | 1,286 | -0.2% | 0.04% | 0.0% |
| Q4 2022 | $218,241 | -10.6% | 1,289 | -1.1% | 0.04% | -12.0% |
| Q3 2022 | $244,000 | -95.3% | 1,303 | -95.9% | 0.05% | -95.1% |
| Q2 2022 | $5,188,000 | +724.8% | 31,948 | +855.7% | 1.02% | +1058.0% |
| Q1 2022 | $629,000 | +17.1% | 3,343 | +64.8% | 0.09% | +17.3% |
| Q4 2021 | $537,000 | -9.6% | 2,029 | -1.3% | 0.08% | 0.0% |
| Q3 2021 | $594,000 | +44.5% | 2,056 | -0.0% | 0.08% | +29.3% |
| Q2 2021 | $411,000 | +1.2% | 2,057 | -1.4% | 0.06% | -1.7% |
| Q1 2021 | $406,000 | +21.2% | 2,087 | +19.3% | 0.06% | +9.3% |
| Q4 2020 | $335,000 | +28.8% | 1,749 | -0.7% | 0.05% | 0.0% |
| Q3 2020 | $260,000 | -6.5% | 1,761 | -21.7% | 0.05% | -8.5% |
| Q2 2020 | $278,000 | -94.2% | 2,248 | -95.5% | 0.06% | -95.9% |
| Q1 2020 | $4,780,000 | +6.7% | 49,516 | +2.3% | 1.44% | +56.8% |
| Q4 2019 | $4,478,000 | +36.8% | 48,414 | +13.5% | 0.92% | +5.7% |
| Q3 2019 | $3,273,000 | – | 42,672 | – | 0.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |